Who has invested in Loyal?

age1, Baillie Gifford are named among the investors backing Loyal.

Loyal Funding: $100M Raised, Series C (2026)

Loyal funding overview

Loyal is a Biotech company. Loyal has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2026. The round record for Loyal runs through 2026; nothing later has been disclosed. Investors on record include age1, Baillie Gifford. 2 distinct backers are named across the disclosed rounds.

Loyal at a glance

Total raised: $100M
Latest round: Series C
Latest round date: February 2026
Industry: Biotech
Notable investors: age1, Baillie Gifford

Frequently asked about Loyal funding

How much has Loyal raised?: Loyal has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Loyal?: age1, Baillie Gifford are named among the investors backing Loyal.
What was the latest Loyal funding round?: The most recent disclosed round is a Series C, announced in February 2026.
Where is Loyal based?: No headquarters location is disclosed for Loyal.
What sector does Loyal operate in?: Loyal is tracked under Biotech, with $100M in disclosed funding.
When did Loyal last raise?: The last disclosed Loyal round closed in February 2026 at Series C.

Every Loyal figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.

Loyal Funding: $100M Raised, Series C (2026)

Loyal funding overview

Loyal at a glance

Frequently asked about Loyal funding

Companies related to Loyal (19)

Browse related funding lists (4)